Kim Smith-Whitley
2021
Compensation breakdown
| Non-Equity Incentive Plan | $126,000 |
|---|---|
| Option Awards | $842,603 |
| Salary | $340,000 |
| Stock Awards | $1,484,042 |
| Other | $18,000 |
| Total | $2,810,645 |
Smith-Whitley received $1.5M in stock awards, accounting for 53% of the total pay in 2021.
Smith-Whitley also received $126K in non-equity incentive plan, $842.6K in option awards, $340K in salary and $18K in other compensation.
Rankings
In 2021, Kim Smith-Whitley's compensation ranked 4,678th out of 12,415 executives tracked by ExecPay. In other words, Smith-Whitley earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,678 out of 12,415 | 62nd |
Division Manufacturing | 1,939 out of 5,505 | 65th |
Major group Chemicals And Allied Products | 810 out of 2,375 | 66th |
Industry group Drugs | 723 out of 2,096 | 66th |
Industry Pharmaceutical Preparations | 516 out of 1,546 | 67th |
Pay ratio
| Kim Smith-Whitley's Pay | $2,810,645 |
|---|---|
| Median Employee's Pay | $345,973 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Kim Smith-Whitley was $2,810,645.
The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.
The ratio of Kim Smith-Whitley's pay to the pay of median employee was therefore 8 to one.
Smith-Whitley's colleagues
We found four more compensation records of executives who worked with Kim Smith-Whitley at Global Blood Therapeutics in 2021.